Zitate

APA-Zitierstil (7. Ausg.)
Sen, A., Toniolo, S., Tai, X. Y., Akinola, M., Symmonds, M., Mura, S., . . . Husain, M. (2024). Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: A pilot, double‐blind placebo‐controlled crossover trial. Wiley.
Chicago-Zitierstil (17. Ausg.)
Sen, Arjune, et al. Safety, Tolerability, and Efficacy Outcomes of the Investigation of Levetiracetam in Alzheimer's Disease (ILiAD) study: A Pilot, Double‐blind Placebo‐controlled Crossover Trial. Wiley, 2024.
MLA-Zitierstil (9. Ausg.)
Sen, Arjune, et al. Safety, Tolerability, and Efficacy Outcomes of the Investigation of Levetiracetam in Alzheimer's Disease (ILiAD) study: A Pilot, Double‐blind Placebo‐controlled Crossover Trial. Wiley, 2024.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.